Press Releases - 2023-03-22

Date	Title	Company
22-Mar-2023	AbCellera and RQ Bio Partner to Accelerate the Advancement of New Therapies for Infectious Disease	RQ Biotechnology
22-Mar-2023	TrakCel and Lonza complete integration milestone to combine cell and gene therapy manufacturing and orchestration solutions	TrakCel
22-Mar-2023	Avania Names MedTech Industry Veteran, Todd M. Pope, New Chairman of the Board	Avania
22-Mar-2023	Health-ISAC Releases Annual Report on Current and Emerging Cyber Threats to Healthcare	Newswire
22-Mar-2023	Greenphire Launches Patient-Powered Research Registry Allowing Foundations to Better Engage and Support Patients	Greenphire
22-Mar-2023	Dewpoint Therapeutics partners with Novo Nordisk to explore the field of biomolecular condensates to treat insulin resistance and diabetes progression	Dewpoint Therapeutics
22-Mar-2023	SGD Pharma achieves prestigious gold EcoVadis Sustainability Rating.	SGD Pharma
22-Mar-2023	Sernova: Abstract on First Cohort of its Phase 1/2 Study Involving Islet Transplantation into Cell Pouch Selected for Oral Podium Presentation at American Diabetes Association 83rd Scientific Sessions	Sernova Corp.
22-Mar-2023	‘Innovation key to improving services and reducing waiting lists,’ 90% of NHS Scotland staff say	InnoScot Health
22-Mar-2023	Dermapharm Holding SE: 2022 dividend	Dermapharm Holding SE
22-Mar-2023	NICE recommends OXLUMO®▼ (lumasiran) in England as first therapy to treat underlying cause of ultra-rare condition primary hyperoxaluria type 1 (PH1)	Alnylam UK Limited
22-Mar-2023	New data suggests investigational oral osteoarthritis drug APPA may have a promising senotherapeutic effect with potential in other diseases of ageing	AKL Therapeutics
22-Mar-2023	Aston University to take part in West Midlands Innovation Accelerator to spark growth and innovation	Aston University
22-Mar-2023	ABPI response to MHRA clinical trials framework	ABPI
22-Mar-2023	KITE’S YESCARTA® (AXICABTAGENE CILOLEUCEL) CAR T-CELL THERAPY DEMONSTRATES A STATISTICALLY SIGNIFICANT IMPROVEMENT IN OVERALL SURVIVAL FOR INITIAL TREATMENT OF RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA (LBCL)	Kite
22-Mar-2023	Aptamer launches Optimer®-Fc as a new reagent solution for immunohistochemistry	Aptamer Group plc
22-Mar-2023	Vaccitech’s VTP-200 Ph 1b/2 Study Demonstrates Favorable Tolerability and Immunogenicity Profile at Interim Analysis in Women with Low-Grade Human Papillomavirus (HPV)-related Cervical Lesions	Vaccitech
22-Mar-2023	Global pharmaceutical company moves into life sciences hub White City Place	invoX Pharma Ltd
22-Mar-2023	Brainomix Receives FDA Clearance for Its Flagship Stroke AI Imaging Software	Brainomix
22-Mar-2023	Dupixent® (dupilumab) approved by European Commission as first and only targeted medicine for children as young as six months old with severe atopic dermatitis	Sanofi